Adapting to the Evolving Era of Oncology: Implications and Strategies for Research Institutions

Oncology research is entering a transformative phase, with breakthroughs in biomarker-directed therapies and innovations that are reshaping the treatment landscape. As research institutions navigate this “Golden Era,” ensuring ethical rigor, regulatory compliance, and robust protocol design has never been more critical.

How prepared is your institution to navigate the intricacies of oncology research involving complex genomic data in today’s evolving landscape?

Join Vanessa Hill, Director Research Compliance, Advarra and Michelle Green, Genomics Program Manager, LabCorp for an insightful discussion on the latest ethical and regulatory challenges for research institutions in oncology research.

Learning Objectives:

• Navigate complex ethical considerations in oncology studies
• Implement best practices to ensure adherence to evolving regulatory frameworks
• Proactive approaches for addressing unique challenges in oncology trials, including patient safety and data integrity

• Presenters

Michelle Green

Genomics Program Manager, LabCorp Oncology

Vanessa Hill

Director, Research Compliance, Institutional Research